You are not authorized to access this page.
Search Within

Neeta Pandit-Taskar

Formats
  1. Meeting Abstract (157)
  2. Journal Article (144)
  3. Review (20)
  4. Book Section (17)
  5. Guidelines (5)
  6. Editorial (2)
Groups
  1. Molecular Imaging and Therapy Service (345)
  2. Radiology, Department of (345)
  3. GSK Faculty (145)
  4. Medical Physics (128)
  5. Department of Medicine (122)
  6. Molecular Pharmacology and Chemistry Program Faculty (103)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (77)
  3. Pat Zanzonico (58)
  4. Serge Lyashchenko (53)
  5. Jason Lewis (52)
  6. Kim Kramer (51)

More People

Years
  1. 2025 (7)
  2. 2024 (22)
  3. 2023 (31)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (12)

More Years

Publications
  1. Journal of Nuclear Medicine (67)
  2. Journal of Clinical Oncology (48)
  3. European Journal of Nuclear Medicine and Molecular Imaging (21)
  4. Pediatric Blood and Cancer (21)
  5. Neuro-Oncology (20)
  6. Blood (14)

More Publications

Publishers
  1. Society of Nuclear Medicine (67)
  2. Springer (49)
  3. American Society of Clinical Oncology (48)
  4. Elsevier Inc. (38)
  5. Oxford University Press (23)
  6. Wiley Periodicals, Inc (21)

More Publishers

Results (345)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Positron lymphography via intracervical (18)F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies
    Journal Article

    Mueller, J. J.; Dauer, L. T.; Murali, R.; Iasonos, A.; Pandit-Taskar, N.; Abu-Rustum, N. R.; Grimm, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Phase 0 study to assess [111In]-DOTA-h11B6 to target -human kallikrein-2 (hk2) in men with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Morris, M. J.; O'Donoghue, J. A.; Chetty, D.; Russell, M.; Zulch, E.; Avadhani, A. N.; Divgi, C. R.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Assessing cerebrospinal fluid flow dynamics in pediatric patients with central nervous system tumors treated with intraventricular radioimmunotherapy
    Journal Article

    Kramer, K.; Donzelli, M.; Nwora, E.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting
    Journal Article

    Pandit-Taskar, N.; Postow, M. A.; Hellmann, M. D.; Harding, J. J.; Barker, C. A.; O'Donoghue, J. A.; Ziolkowska, M.; Ruan, S.; Lyashchenko, S. K.; Tsai, F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Restaging [(18)F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance
    Journal Article

    Mahajan, S.; Barker, C. A.; Mauguen, A.; Singh, B.; Pandit-Taskar, N.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies
    Journal Article

    Quinn, B. M.; Gao, Y.; Mahmood, U.; Pandit-Taskar, N.; Behr, G.; Zanzonico, P.; Dauer, L. T.
    BMC Medical Imaging (2020)

    Fulltext@MSK | Save
  • Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for re-induction and targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: SIERRA trial experience at MSKCC
    Meeting Abstract

    Chu, B. P.; Pandit-Taskar, N.; Gyurkocza, B.; Liang, Q.; Miodownik, D.; Reddy, V.; Berger, M. S.; Dauer, L. T.
    Blood (2019)

    Fulltext@MSK | Save
  • Assessing cerebrospinal fluid flow dynamics in pediatric patients with central nervous system tumors
    Meeting Abstract

    Kramer, K.; Donzellie, M.; Nwora, E.; Pandit-Taskar, N.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy and theranostics with alpha emitters
    Review

    Pandit-Taskar, N.
    Journal of Medical Imaging and Radiation Sciences (2019)

    Fulltext@MSK | Save